NCT03203603

Brief Summary

The overall aims of this protocol are to determine whether prenatal supplementation with vitamin C to pregnant smokers can improve pulmonary function and decrease wheeze at 5 years of age in their offspring. This is a continuation of the VCSIP trial, to follow the offspring through 5 years of age. The hypothesis for this protocol is an extension of the VCSIP trial that supplemental vitamin C in pregnant smokers can significantly improve their children's PFTs and decrease the incidence of wheeze.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
242

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2017

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 27, 2017

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

March 28, 2017

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 29, 2017

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 25, 2025

Status Verified

March 1, 2025

Enrollment Period

4.8 years

First QC Date

March 28, 2017

Last Update Submit

March 20, 2025

Conditions

Keywords

asthmapulmonary function testingwheezevitamin Cantioxidantsforced expiratory flows

Outcome Measures

Primary Outcomes (1)

  • Improved pulmonary function, spirometry

    The primary aim of this study is to demonstrate improved pulmonary function at 5 years of age in the offspring of pregnant smokers randomized to vitamin C 500 mg/day versus placebo.

    5 years of age

Secondary Outcomes (1)

  • Decreased incidence of wheeze

    5 years of age

Study Arms (3)

Offspring of smokers who got vitamin C

Offspring of pregnant smokers randomized to vitamin C during the initial randomized portion of the VCSIP study

Other: No active intervention

Offspring of smokers who got placebo

Offspring of pregnant smokers randomized to placebo during the initial randomized portion of the VCSIP study

Other: No active intervention

Offspring of pregnant non-smokers

Offspring of pregnant non-smokers who were followed in a similar fashion during pregnancy as the randomized pregnant smokers

Other: No active intervention

Interventions

This is a follow-up of a randomized trial. No active intervention is being given in the follow-up.

Offspring of pregnant non-smokersOffspring of smokers who got placeboOffspring of smokers who got vitamin C

Eligibility Criteria

Age6 Months - 4 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

This is a follow up of NCT01723696. In that study, pregnant smokers were recruited at obstetric clinics delivering at OHSU, PeaceHealth Southwest Washington Medical Center in Vancouver, Washington or Indiana University in Indianapolis, Indiana. We are now following the offspring of those pregnant smokers (and control group non-smokers).

You may qualify if:

  • Women and their offspring randomized to vitamin C versus placebo during pregnancy as well as pregnant nonsmokers and their offspring enrolled as the reference group in the current RCT.

You may not qualify if:

  • Patients specifically withdrawing consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Indiana University

Indianapolis, Indiana, 46202-5167, United States

Location

Oregon Health and Science University

Portland, Oregon, 97239, United States

Location

Related Publications (4)

  • McEvoy CT, Schilling D, Clay N, Jackson K, Go MD, Spitale P, Bunten C, Leiva M, Gonzales D, Hollister-Smith J, Durand M, Frei B, Buist AS, Peters D, Morris CD, Spindel ER. Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: a randomized clinical trial. JAMA. 2014 May;311(20):2074-82. doi: 10.1001/jama.2014.5217.

    PMID: 24838476BACKGROUND
  • Shorey-Kendrick LE, McEvoy CT, Milner K, Harris J, Brownsberger J, Tepper RS, Park B, Gao L, Vu A, Morris CD, Thompson EE, Ober C, Spindel ER. Vitamin C supplementation to pregnant smokers alters asthma- and allergy-associated CpGs in child buccal DNA at 5 years of age. Clin Epigenetics. 2025 Oct 3;17(1):155. doi: 10.1186/s13148-025-01965-2.

  • Shorey-Kendrick LE, McEvoy CT, Milner K, Harris J, Brownsberger J, Tepper RS, Park B, Gao L, Vu A, Morris CD, Spindel ER. Improvements in lung function following vitamin C supplementation to pregnant smokers are associated with buccal DNA methylation at 5 years of age. Clin Epigenetics. 2024 Feb 27;16(1):35. doi: 10.1186/s13148-024-01644-8.

  • McEvoy CT, Shorey-Kendrick LE, Milner K, Harris J, Vuylsteke B, Cunningham M, Tiller C, Stewart J, Schilling D, Brownsberger J, Titus H, MacDonald KD, Gonzales D, Vu A, Park BS, Spindel ER, Morris CD, Tepper RS. Effect of Vitamin C Supplementation for Pregnant Smokers on Offspring Airway Function and Wheeze at Age 5 Years: Follow-up of a Randomized Clinical Trial. JAMA Pediatr. 2023 Jan 1;177(1):16-24. doi: 10.1001/jamapediatrics.2022.4401.

Biospecimen

Retention: SAMPLES WITH DNA

buccal swabs, hair, blood and urine will be collected.

MeSH Terms

Conditions

AsthmaRespiratory Sounds

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Cindy McEvoy, MD, MCR

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, MCR

Study Record Dates

First Submitted

March 28, 2017

First Posted

June 29, 2017

Study Start

March 27, 2017

Primary Completion

December 31, 2021

Study Completion

December 31, 2024

Last Updated

March 25, 2025

Record last verified: 2025-03

Locations